HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Amelioration of hyperglycemia and metabolic syndromes in type 2 diabetic KKA(y) mice by poly(gamma-glutamic acid)oxovanadium(IV) complex.

Abstract
Recently, we found that poly(gamma-glutamic acid)oxovanadium(IV) complex (VO(gamma-pga)) exhibits a potent antidiabetic activity in streptozotocin (STZ)-induced type 1 diabetic mice. This result prompted us to examine its ability to treat the type 2 diabetic model KKA(y) mice with insulin resistance. We studied the in vivo antidiabetic activity of VO(gamma-pga), compared with that of vanadium(IV) oxide sulfate (VS) as control. Both compounds were orally administered at doses of 5-10 mg (0.1-0.2 mmol) V kg(-1) body mass to the KKA(y) mice for 30 days. VO(gamma-pga) normalized the hyperglycemia within 21 days, whereas VS lowered the blood glucose concentration only by a small degree. In addition, the glucose intolerance, HbA(1c) level, hyperinsulinemia, hypercholesterolemia, and hyperleptinemia were significantly improved in VO(gamma-pga)-treated KKA(y) mice compared with those treated with VS. Based on these observations, VO(gamma-pga) is proposed to be the first orally active oxovanadium(IV)-polymer complex for the efficacious treatment of not only type 2 diabetes but also metabolic syndrome in animals.
AuthorsSubarna Karmaker, Tapan K Saha, Yutaka Yoshikawa, Hiromu Sakurai
JournalChemMedChem (ChemMedChem) Vol. 2 Issue 11 Pg. 1607-12 (Nov 2007) ISSN: 1860-7187 [Electronic] Germany
PMID17768733 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Blood Glucose
  • Insulin
  • Leptin
  • poly(gamma-glutamic acid)
  • Polyglutamic Acid
  • Vanadates
Topics
  • Animals
  • Blood Glucose (analysis)
  • Diabetes Mellitus, Experimental (complications, drug therapy)
  • Glucose Tolerance Test
  • Hyperglycemia (complications, drug therapy)
  • Insulin (blood)
  • Leptin (physiology)
  • Male
  • Metabolic Syndrome (complications, drug therapy)
  • Mice
  • Mice, Inbred C57BL
  • Obesity (drug therapy)
  • Polyglutamic Acid (analogs & derivatives, therapeutic use)
  • Vanadates (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: